Healthcare provider profile · identity verified

Phyllis J Atkinson, NP

Nurse Practitioner · MAINEVILLE, OH · NPI 1992849509

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	633	65
Atorvastatin Calcium	Atorvastatin Calcium	516	49
Sertraline Hcl	Sertraline Hcl	512	36
Losartan Potassium	Losartan Potassium	398	38
Memantine Hcl	Memantine Hcl	374	25
Lisinopril	Lisinopril	332	37
Amlodipine Besylate	Amlodipine Besylate	306	41
Donepezil Hcl	Donepezil Hcl	300	27
Furosemide	Furosemide	290	39
Duloxetine Hcl	Duloxetine Hcl	289	23
Metoprolol Succinate	Metoprolol Succinate	250	37
Eliquis	Apixaban	240	29
Omeprazole	Omeprazole	218	28
Potassium Chloride	Potassium Chloride	218	31
Gabapentin	Gabapentin	213	26
Allopurinol	Allopurinol	184	16
Mirtazapine	Mirtazapine	184	23
Hydrochlorothiazide	Hydrochlorothiazide	176	16
Metoprolol Tartrate	Metoprolol Tartrate	175	17
Metformin Hcl	Metformin Hcl	150	11
Quetiapine Fumarate	Quetiapine Fumarate	148	14
Metformin Hcl Er	Metformin Hcl	133	13
Famotidine	Famotidine	128	16
Januvia	Sitagliptin Phosphate	127	suppressed
Clopidogrel	Clopidogrel Bisulfate	114	suppressed
Trulicity	Dulaglutide	101	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	100	16
Alendronate Sodium	Alendronate Sodium	91	suppressed
Hydralazine Hcl	Hydralazine Hcl	86	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	82	suppressed
Montelukast Sodium	Montelukast Sodium	81	suppressed
Ropinirole Hcl	Ropinirole Hcl	80	suppressed
Ranolazine Er	Ranolazine	76	suppressed
Folic Acid	Folic Acid	73	suppressed
Jardiance	Empagliflozin	71	suppressed
Xarelto	Rivaroxaban	71	suppressed
Loperamide	Loperamide Hcl	70	suppressed
Simvastatin	Simvastatin	69	11
Divalproex Sodium	Divalproex Sodium	67	11
Pantoprazole Sodium	Pantoprazole Sodium	66	21
Propranolol Hcl Er	Propranolol Hcl	66	suppressed
Pravastatin Sodium	Pravastatin Sodium	65	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	62	50
Rosuvastatin Calcium	Rosuvastatin Calcium	62	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	62	suppressed
Digoxin	Digoxin	60	suppressed
Carvedilol	Carvedilol	59	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	58	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	57	suppressed
Baclofen	Baclofen	53	suppressed
Valsartan	Valsartan	52	suppressed
Vascepa	Icosapent Ethyl	52	suppressed
Brilinta	Ticagrelor	51	suppressed
Prednisone	Prednisone	50	26
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	49	suppressed
Sucralfate	Sucralfate	49	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	49	19
Midodrine Hcl	Midodrine Hcl	46	suppressed
Pregabalin	Pregabalin	46	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	44	23
Memantine Hcl Er	Memantine Hcl	44	suppressed
Tramadol Hcl	Tramadol Hcl	44	14
Latanoprost	Latanoprost	43	suppressed
Buspirone Hcl	Buspirone Hcl	41	suppressed
Citalopram Hbr	Citalopram Hydrobromide	41	suppressed
Ezetimibe	Ezetimibe	40	suppressed
Amiodarone Hcl	Amiodarone Hcl	39	suppressed
Glimepiride	Glimepiride	39	suppressed
Olanzapine	Olanzapine	38	suppressed
Trazodone Hcl	Trazodone Hcl	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	22
Finasteride	Finasteride	31	suppressed
Torsemide	Torsemide	31	suppressed
Alprazolam	Alprazolam	30	suppressed
Diltiazem Hcl	Diltiazem Hcl	30	suppressed
Spironolactone	Spironolactone	30	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	22
Nystatin	Nystatin	28	16
Primidone	Primidone	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	suppressed
Terazosin Hcl	Terazosin Hcl	27	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Lovastatin	Lovastatin	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Clonidine	Clonidine	25	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	25	suppressed
Cefuroxime	Cefuroxime Axetil	24	19
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Cephalexin	Cephalexin	23	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Rivastigmine	Rivastigmine Tartrate	23	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Galantamine Er	Galantamine Hbr	21	suppressed
Methimazole	Methimazole	21	suppressed
Methocarbamol	Methocarbamol	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	15
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Minocycline Hcl	Minocycline Hcl	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	19	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	19	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Fluconazole	Fluconazole	16	11
Metronidazole	Metronidazole	16	suppressed
Risperidone	Risperidone	16	suppressed
Rivastigmine	Rivastigmine	16	suppressed
Invokana	Canagliflozin	15	suppressed
Rhopressa	Netarsudil Mesylate	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	13	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Irbesartan	Irbesartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error